Company research / PCYN

Procyon Corp (PCYN)

SEC name PROCYON CORP · CIK 0000812306 · OTC · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated CO
  • Fiscal year ends Jun 30

Not updated since 2024-06-30. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

For the year ended 2024-06-30, Procyon Corp reported revenue of $4.98M. Revenue grew 6.4% from the prior annual period.

Key ratios (year ended 2024-06-30)

78.1%
Gross margin
-4.6%
Operating margin
-6.8%
Net margin
-14.9%
Return on year-end equity
6.4%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2024-11-08

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

Period ended2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-31
Revenue$4.98Mn/an/an/a$4.69Mn/an/an/a$4.84Mn/a
Cost of Revenue$1.09Mn/an/an/a$1.12Mn/an/an/a$1.36Mn/a
Gross Profit$3.89Mn/an/an/a$3.57Mn/an/an/a$3.49Mn/a
R&D Expense$30.1Kn/an/an/a$30.6Kn/an/an/a$30.0Kn/a
Operating Income-$231.7Kn/an/an/a-$97.4Kn/an/an/a-$237.2Kn/a
Net Income-$341.1Kn/an/an/a-$50.2Kn/an/an/a-$209.8Kn/a
EPS (Diluted)-$0.04n/an/an/a-$0.01n/an/an/a-$0.03n/a
Total Assets$3.20Mn/an/an/a$3.56Mn/an/an/a$3.80Mn/a
Total Liabilities$917.1Kn/an/an/a$946.0Kn/an/an/a$1.13Mn/a
Shareholders' Equity$2.29M$2.25M$2.35M$2.59M$2.62M$2.61M$2.64M$2.66M$2.67M$2.75M
Operating Cash Flow-$61.3Kn/an/an/a$145.5Kn/an/an/a-$383.5Kn/a
Capital Expenditures$63.9Kn/an/an/a$180.1Kn/an/an/a$82.6Kn/a
Free Cash Flow-$125.2Kn/an/an/a-$34.7Kn/an/an/a-$466.1Kn/a
Shares Outstanding8.12Mn/an/an/a8.09Mn/an/an/a8.09Mn/a
Weighted Average Diluted Shares8.12Mn/an/an/a8.09Mn/an/an/a8.09Mn/a
EPS (Basic)-$0.04n/an/an/a-$0.01n/an/an/a-$0.03n/a